EastWest Bioscience (EAST:TSXV) is a vertically integrated wellness company with a multitude of business units and assets that allow for a seed-to-sale supply chain management. We source our raw material, process, manufacture, test, brand, market, and distribute our products to our customers in Canada, the United States, and beyond.

EWBS_Services-Graphic-v4-04

EastWest Bioscience Business Units

Press Releases

February 5, 2021

EastWest Bioscience Announces Grant of Options and Debt Settlement

VANCOUVER, BC / ACCESSWIRE / February 5, 2021 / EastWest Bioscience (the “Company” or “EastWest”) (TSXV:EAST) announces, subject to its stock option plan, the grant of 1,720,000 […]
February 4, 2021

Early Warning Report in Accordance with National Instrument 62-103

PENTICTON, BC / ACCESSWIRE / February 2, 2021 / Ms. Ciska Asriel issues this press release pursuant to Part 3 – Early Warning Requirements of National Instrument 62-103 with […]
January 6, 2021

EastWest Announces Resignation of CFO and Appointment of Interim CFO

PENTICTON, BC, January 6, 2021 – EastWest Bioscience Inc. (“EastWest” or the “Corporation“) announces that the Corporation has appointed Ciska Asriel to serve as interim Chief […]
January 4, 2021

Default Announcement

VANCOUVER, BC, January 4, 2021 – EastWest Bioscience Inc. (“EastWest” or the “Corporation“) provides this default announcement indicating EastWest’s failure to file its interim financial statements […]